Jakub Neradil

Masaryk University

Czech Republic

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Karolína Bořánková

Karolinska Institutet

SWEDEN

View details

Des R. Richardson

Griffith University

AUSTRALIA

View details

Patric Jansson

Senior Research Fellow - Senior Lecturer

University of Sydney

AUSTRALIA

View details

Renata Veselska

St. Anne's University Hospital

CZECH REPUBLIC

View details

Michal Mahdal

Lékařská Fakulta Univerzita Palackého v Olomouci

CZECH REPUBLIC

View details

Jaroslav Sterba

University Hospital Brno

CZECH REPUBLIC

View details

Jiří Urban

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jakub Neradil

Research Interests

Explore related searches

Contact this professor

Articles (12)

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits

Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma

Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors

Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors

Serotonin limits generation of chromaffin cells during adrenal organ development

Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling

Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFR beta Signaling

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration

Collaborators (7)

Karolína Bořánková

Des R. Richardson

Patric Jansson

Renata Veselska

Michal Mahdal

Jaroslav Sterba

Jiří Urban

Make your next move.